Continuing to Invest in Canada and our Customers: We strive to be first to market with new launches and ensure product availability to Canadian pharmacies and their patients.
New! ACT Gliclazide MR 30 mg
More about Actavis products
Provide your name and email address to be notified as Cobalt products transition to Actavis!
CO to ACT Product Transition
Over the next twenty-four months Cobalt-labelled products will gradually transition to the new Actavis brand.
More information about the transition of products from Cobalt to Actavis